Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH)

Trial Profile

Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 26 Mar 2018

At a glance

  • Drugs Guanfacine (Primary)
  • Indications Back pain; Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Mar 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
    • 20 Mar 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
    • 15 Sep 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top